161 – 170 of 534
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
(
- Contribution to journal › Article
-
Mark
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
(
- Contribution to journal › Article
-
Mark
Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
(
- Contribution to journal › Article
-
Mark
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
(
- Contribution to journal › Article
-
Mark
Cell of Origin of Breast Cancer: An Updated Hypothesis Merging Epidemiological Data with Molecular Biology
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
(
- Contribution to journal › Article
-
Mark
Metal-on-metal joint bearings and hematopoetic malignancy A review
(
- Contribution to journal › Scientific review
-
Mark
A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
A prospective, population-based study of 40000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
(
- Contribution to journal › Article